Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CGS.AU
- Price
- 1.39
- Stock movement down
- -0.01 (-1.07%)
- Company name
- CogState Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Health Information Services
- Market cap
- 240.12M
- Ent value
- 226.91M
- Price/Sales
- 2.07
- Price/Book
- 5.87
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 14.96
- Forward P/E
- 23.17
- PEG
- -
- EPS growth
- -
- 1 year return
- 8.17%
- 3 year return
- -14.58%
- 5 year return
- 33.32%
- 10 year return
- 18.83%
Last updated: 2025-04-05
DIVIDENDS
CGS.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 14.96 |
| Price to OCF | 19.29 |
| Price to FCF | 25.06 |
| Price to EBITDA | 11.53 |
| EV to EBITDA | 10.90 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.07 |
| Price to Book | 5.87 |
| EV to Sales | 1.96 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 172.74M |
| EPS (TTM) | 0.09 |
| FCF per share (TTM) | 0.06 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 115.93M |
| Gross profit (TTM) | 48.10M |
| Operating income (TTM) | 18.07M |
| Net income (TTM) | 16.05M |
| EPS (TTM) | 0.09 |
| EPS (1y forward) | 0.06 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 41.49% |
| Operating margin (TTM) | 15.59% |
| Profit margin (TTM) | 13.85% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 30.12M |
| Net receivables | 10.08M |
| Total current assets | 43.46M |
| Goodwill | 0.00 |
| Intangible assets | 10.48M |
| Property, plant and equipment | 4.75M |
| Total assets | 57.84M |
| Accounts payable | 302.17K |
| Short/Current long term debt | 672.72K |
| Total current liabilities | 12.58M |
| Total liabilities | 16.92M |
| Shareholder's equity | 40.92M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 12.45M |
| Capital expenditures (TTM) | 2.87M |
| Free cash flow (TTM) | 9.58M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 39.22% |
| Return on Assets | 27.75% |
| Return on Invested Capital | 39.02% |
| Cash Return on Invested Capital | 23.29% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.36 |
| Daily high | 1.42 |
| Daily low | 1.36 |
| Daily Volume | 281K |
| All-time high | 2.65 |
| 1y analyst estimate | 1.45 |
| Beta | 0.09 |
| EPS (TTM) | 0.09 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CGS.AU | S&P500 | |
| Current price drop from All-time high | -47.55% | -17.56% |
| Highest price drop | -88.60% | -56.47% |
| Date of highest drop | 9 Jul 2019 | 9 Mar 2009 |
| Avg drop from high | -45.70% | -11.07% |
| Avg time to new high | 78 days | 12 days |
| Max time to new high | 1230 days | 1805 days |
COMPANY DETAILS
Marketcap
240.12M
Marketcap category
Small-cap
Description
Cogstate Limited, a neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research. Its cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. The company is involved in the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its technology and associated services are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In addition, the company provides Cognigram, a computerized test to aid healthcare professionals for cognitive decline. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
Employees
160
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found